Published in J Cereb Blood Flow Metab on January 01, 2016
The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis. Biochim Biophys Acta (2015) 0.99
Cerebrovascular disease in ageing and Alzheimer's disease. Acta Neuropathol (2015) 0.87
Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease. Acta Neuropathol (2016) 0.85
Progression of Brain Network Alterations in Cerebral Amyloid Angiopathy. Stroke (2016) 0.78
Hypertension and Stroke in Patients with Left Ventricular Assist Devices (LVADs). Curr Hypertens Rep (2016) 0.76
Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities. Front Neurol (2016) 0.75
Microbleeds on MRI are associated with microinfarcts on autopsy in cerebral amyloid angiopathy. Neurology (2016) 0.75
Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases. Neurochem Res (2017) 0.75
Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy. J Alzheimers Dis (2017) 0.75
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol (2010) 5.76
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet (2002) 5.05
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron (2004) 4.29
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Myelination and support of axonal integrity by glia. Nature (2010) 3.54
Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain (2005) 3.34
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci (2004) 3.09
Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke (2011) 3.04
Vascular risk factors and dementia: how to move forward? Neurology (2009) 2.97
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol (2008) 2.90
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1984) 2.86
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology (2009) 2.47
Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem (2004) 2.45
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol (2014) 2.39
Course of cerebral amyloid angiopathy-related inflammation. Neurology (2007) 2.33
Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry (2011) 2.32
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol (2013) 2.29
Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology (2012) 2.23
Amyloid angiopathy-related vascular cognitive impairment. Stroke (2004) 2.21
Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke (2003) 2.19
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol (2008) 2.10
Rapid appearance of new cerebral microbleeds after acute ischemic stroke. Neurology (2009) 2.08
White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology (2004) 2.07
Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain (2004) 2.07
Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology (2006) 2.06
Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol (2008) 2.03
Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol (2010) 1.96
Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol (2004) 1.95
The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol (2006) 1.91
Estimating cerebral microinfarct burden from autopsy samples. Neurology (2013) 1.87
Microbleeds versus macrobleeds: evidence for distinct entities. Stroke (2009) 1.83
Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain (2011) 1.82
Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol (2003) 1.82
Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (2010) 1.78
Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology (2014) 1.77
Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke (2004) 1.74
White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry (2009) 1.74
Cerebral microbleeds and cognition in patients with symptomatic small vessel disease. Stroke (2013) 1.72
Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol (2009) 1.69
Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology (2001) 1.69
Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol (2011) 1.65
Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology (2012) 1.63
Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis (2011) 1.63
Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology (2012) 1.62
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke (2009) 1.57
Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke (2002) 1.57
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain (2007) 1.55
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol (1996) 1.54
Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology (2003) 1.53
Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol (1986) 1.50
In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI. J Cereb Blood Flow Metab (2012) 1.49
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke (2009) 1.46
11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology (2010) 1.43
Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology (2008) 1.42
Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol (2011) 1.41
AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol Aging (2007) 1.39
Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol (2011) 1.34
Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology (2013) 1.33
Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes (2013) 1.29
A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol (2002) 1.29
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol (2012) 1.29
Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology (2010) 1.29
Coevolution of white matter hyperintensities and cognition in the elderly. Neurology (2012) 1.28
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. J Neurosci (2008) 1.27
Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging (2006) 1.26
Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry (2006) 1.25
Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol (1995) 1.22
Blood-brain barrier and cerebral small vessel disease. J Neurol Sci (2010) 1.22
Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol (2006) 1.21
Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology (2005) 1.20
Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke (2008) 1.19
Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage (2011) 1.18
White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology (2013) 1.18
Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes (2014) 1.17
Cortical microhemorrhages cause local inflammation but do not trigger widespread dendrite degeneration. PLoS One (2011) 1.17
Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain (2011) 1.16
Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy - a histopathological assessment. Dement Geriatr Cogn Disord (2002) 1.16
Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke (2010) 1.16
Galantamine treatment of vascular dementia: a randomized trial. Neurology (2007) 1.16
Diffusion tensor imaging. Methods Mol Biol (2011) 1.13
Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging (2008) 1.13
Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke (2002) 1.12
Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem (1995) 1.11
Cerebrovascular lesions induce transient β-amyloid deposition. Brain (2011) 1.10
Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2. Brain Pathol (2008) 1.10
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med (2007) 3.61
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med (2009) 3.44
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med (2004) 3.06
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis (2006) 2.96
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke (2008) 2.72
Disconnection of the ascending arousal system in traumatic coma. J Neuropathol Exp Neurol (2013) 2.38
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol (2013) 2.29
Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care (2012) 2.25
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17
Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. Heart Rhythm (2006) 2.13
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol (2004) 1.95
The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol (2006) 1.91
Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90
Beta-amyloid, blood vessels, and brain function. Stroke (2009) 1.89
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89
Estimating cerebral microinfarct burden from autopsy samples. Neurology (2013) 1.87
Cerebral amyloid angiopathy: a systematic review. J Clin Neurol (2011) 1.77
The effect of survival bias on case-control genetic association studies of highly lethal diseases. Circ Cardiovasc Genet (2011) 1.71
Performance of the St. Jude Medical Riata leads. Heart Rhythm (2008) 1.71
COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol (2012) 1.62
Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care (2010) 1.61
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol (2008) 1.60
Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol (2011) 1.59
Acute respiratory distress syndrome after spontaneous intracerebral hemorrhage*. Crit Care Med (2013) 1.58
Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm (2010) 1.58
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain (2007) 1.55
Should anticoagulation be resumed after intracerebral hemorrhage? Cleve Clin J Med (2010) 1.53
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol (2011) 1.47
Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke (2009) 1.46
COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet (2011) 1.38
Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders. J Neuropathol Exp Neurol (2012) 1.38
Validation of intracranial area as a surrogate measure of intracranial volume when using clinical MRI. J Neuroimaging (2007) 1.33
Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology (2013) 1.33
Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis (2013) 1.30
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol (2012) 1.29
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke (2008) 1.26
Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci (2006) 1.24
Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol (2009) 1.23
MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke (2010) 1.23
Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke (2012) 1.19
Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke (2008) 1.19
Anemia and hematoma volume in acute intracerebral hemorrhage. Crit Care Med (2009) 1.17
Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol (2013) 1.15
CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care (2012) 1.14
Cerebrovascular lesions induce transient β-amyloid deposition. Brain (2011) 1.10
The genetic architecture of intracerebral hemorrhage. Stroke (2008) 1.08
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J Neurochem (2009) 1.08
Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci (2007) 1.07
White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging. Stroke (2006) 1.05
Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovasc Dis (2002) 1.04
Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology (2012) 1.03
CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke (2009) 1.02
Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail (2011) 1.02
Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke (2013) 1.02
Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am J Hum Genet (2010) 1.02
Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol (2011) 1.01
Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord (2010) 1.01
Spot sign score predicts rapid bleeding in spontaneous intracerebral hemorrhage. Emerg Radiol (2012) 1.01
Packed red blood cell transfusion and decreased mortality in intracerebral hemorrhage. Neurosurgery (2011) 1.01
Red meets white: do microbleeds link hemorrhagic and ischemic cerebrovascular disease? Neurology (2009) 1.00
Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol (2005) 0.99
Body mass index and etiology of intracerebral hemorrhage. Stroke (2011) 0.98
Modeling intracerebral hemorrhage growth and response to anticoagulation. PLoS One (2012) 0.98
Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhage. Neurocrit Care (2010) 0.98
Common mitochondrial sequence variants in ischemic stroke. Ann Neurol (2010) 0.97
Hemorrhagic stroke. Neuroimaging Clin N Am (2005) 0.97
Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage. Stroke (2012) 0.96
Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help? Stroke (2008) 0.95
Early edema in warfarin-related intracerebral hemorrhage. Neurocrit Care (2007) 0.93
Intracerebral hemorrhage. Handb Clin Neurol (2009) 0.93
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. J Neurol Neurosurg Psychiatry (2013) 0.93
Abeta species, including IsoAsp23 Abeta, in Iowa-type familial cerebral amyloid angiopathy. Acta Neuropathol (2002) 0.92
Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury. Am J Pathol (2012) 0.92
The pattern and pace of hyperacute hemorrhage expansion. Neurocrit Care (2012) 0.92
Semi-Automated Detection of Cerebral Microbleeds on 3.0 T MR Images. PLoS One (2013) 0.91
Personalized approaches to clopidogrel therapy: are we there yet? Stroke (2010) 0.90
Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation? J Gen Intern Med (2009) 0.90
Life imitates art: anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy. Neurology (2011) 0.90
A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis. J Neurol Sci (2008) 0.89
Prolonged emergency department length of stay is not associated with worse outcomes in patients with intracerebral hemorrhage. Neurocrit Care (2012) 0.89
Treatment and prevention of primary intracerebral hemorrhage. Semin Neurol (2005) 0.88
Burden of blood pressure-related alleles is associated with larger hematoma volume and worse outcome in intracerebral hemorrhage. Stroke (2013) 0.88